Richard Burr is principal policy advisor and chair of DLA Piper’s Health Policy Strategic Consulting practice within the global legal firm’s Regulatory and Government Affairs practice group. He provides policy advice, strategic consulting and a wide range of related services to life sciences and healthcare clients navigating a rapidly changing policy landscape and significant regulatory and political uncertainty.
Prior to joining DLA Piper, Richard served nearly three decades in federal service — five terms in the House of Representatives and three terms in the Senate. He was chairman and a senior member of the Senate’s Select Committee on Intelligence and served as an influential member of the Finance Committee for 12 years.
Richard is widely known as one of the foremost government authorities in healthcare and life sciences policy. His many legislative accomplishments include the 1997 FDA Modernization Act and the Pandemic All Hazards Preparedness Act, which created the Biomedical Advanced Research and Development Authority (BARDA) and was critical in the rapid development of the COVID-19 pandemic vaccine.
Richard earned a Bachelor of Arts in communication from Wake Forest University.